Treatments:Cancer
From Proteopedia
(Difference between revisions)
| Line 30: | Line 30: | ||
* [[Sprycel]] - Generic: Dasatinib | * [[Sprycel]] - Generic: Dasatinib | ||
* [[Sutent]] - Generic: Sunitinib | * [[Sutent]] - Generic: Sunitinib | ||
| - | * [[Tasigna]] - Generic: Nilotinib | + | * [[Tasigna]] - Generic: [[Nilotinib]] |
=====[[Vascular Endothelial Growth Factor]] Inhibitor===== | =====[[Vascular Endothelial Growth Factor]] Inhibitor===== | ||
* [[Avastin]] - Generic: Bevacizumab | * [[Avastin]] - Generic: Bevacizumab | ||
Revision as of 10:51, 23 January 2019
Anti-CD20 Monoclonal AntibodyAnti-melanoma Monoclonal Antibody
B-Raf Kinase Inhibitor
Chemotherapy
Dihydrofolate Reductase Inhibitor
Epidermal Growth Factor Receptor Inhibitor
Estrogen Receptor Modulator
Multiple Receptor Tyrosine Kinase (VEGFR, PDGFR, EGFR, KIT, Abl) Inhibitor
Vascular Endothelial Growth Factor Inhibitor
|
Proteopedia Page Contributors and Editors (what is this?)
David Canner, Michal Harel, Alexander Berchansky, Karsten Theis
